Profund Advisors LLC Emergent Bio Solutions Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 27,243 shares of EBS stock, worth $279,785. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,243

Holding current value

$279,785

% of portfolio

0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.72 - $14.77 $155,829 - $402,379	27,243 New	27,243 $227,000
Q2 2023 Aug 10, 2023	BUY	$7.35 - $13.21 $245,563 - $441,346	33,410 Added 45.9%	106,196 $780,000
Q1 2023 May 11, 2023	BUY	$7.79 - $16.29 $567,002 - $1.19 Million	72,786 New	72,786 $754,000
Q2 2022 Aug 01, 2022	SELL	$27.42 - $43.63 $82,314 - $130,977	-3,002 Reduced 23.76%	9,635 $299,000
Q1 2022 May 10, 2022	BUY	$36.48 - $52.22 $24,332 - $34,830	667 Added 5.57%	12,637 $519,000
Q4 2021 Feb 08, 2022	BUY	$33.11 - $55.01 $15,959 - $26,514	482 Added 4.2%	11,970 $520,000
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $6,709 - $8,850	-134 Reduced 1.15%	11,488 $575,000
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $10,076 - $14,321	-178 Reduced 1.51%	11,622 $732,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $150,040 - $217,830	-1,740 Reduced 12.85%	11,800 $1.1 Million
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $137,597 - $193,734	1,738 Added 14.73%	13,540 $1.21 Million
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $661,750 - $1.09 Million	8,079 Added 217.0%	11,802 $1.22 Million
Q2 2020 Aug 03, 2020	BUY	$54.33 - $89.52 $202,270 - $333,282	3,723 New	3,723 $294,000
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $227,556 - $317,121	-4,612 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$51.21 - $59.06 $39,431 - $45,476	-770 Reduced 14.31%	4,612 $249,000
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $50,019 - $70,470	1,232 Added 29.69%	5,382 $281,000
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $9,461 - $12,764	-237 Reduced 5.4%	4,150 $200,000
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $48,326 - $66,292	-1,002 Reduced 18.59%	4,387 $222,000
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $170,116 - $223,967	-3,058 Reduced 36.2%	5,389 $319,000
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $9,993 - $12,769	192 Added 2.33%	8,447 $556,000
Q2 2018 Aug 13, 2018	BUY	$48.33 - $55.64 $39,630 - $45,624	820 Added 11.03%	8,255 $417,000
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $92,035 - $112,641	2,071 Added 38.61%	7,435 $391,000
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $4,305 - $5,443	-114 Reduced 2.08%	5,364 $249,000
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $187,018 - $221,585	5,478	5,478 $222,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $512M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Emergent Bio Solutions Inc. Transaction History